Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23608959 | 0.81 | SMN1; SMN2 (0.42) | SMN1; SMN2HTTCYP19A1TP53NAMPT | |
| SCHEMBL23609064 | 0.80 | SMN1; SMN2 (0.44) | SMN1; SMN2HTTCYP19A1TP53NAMPT | |
| SCHEMBL23609144 | 0.78 | SMN1; SMN2 (0.46) | SMN1; SMN2HTTCYP19A1TP53MAPT | |
| SCHEMBL23608999 | 0.77 | CYP19A1 (0.43) | SMN1; SMN2HTTCYP19A1TP53MAPT | |
| SCHEMBL29974486 | 0.76 | SMN1; SMN2 (0.40) | SMN1; SMN2HTTCYP19A1TP53TDO2 | |
| SCHEMBL28852496 | 0.76 | SMN1; SMN2 (0.40) | SMN1; SMN2HTTCYP19A1TP53TDO2 | |
| SCHEMBL23608983 | 0.75 | CYP19A1 (0.43) | SMN1; SMN2HTTCYP19A1TP53MAPT | |
| SCHEMBL23608965 | 0.75 | CYP19A1 (0.41) | SMN1; SMN2HTTCYP19A1TP53NAMPT | |
| SCHEMBL23609006 | 0.73 | SMN1; SMN2 (0.44) | SMN1; SMN2HTTCYP19A1TP53NAMPT | |
| SCHEMBL30406544 | 0.72 | CYP19A1 (0.40) | SMN1; SMN2CYP19A1TP53NAMPTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230117592-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2023-04-20 | — | — | US | disclosed |
| WO-2021133689-A2 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230117592-A1 | LIPOXYGENASE INHIBITORS | ALOX15B, ALOX12, ALOX5 | SMN1; SMN2 243/4885HTT 549/4885CYP19A1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.